Related Experiment Video
Updated: Apr 26, 2026

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
Heart diastolic dysfunction in patients with systemic sclerosis.
Michał Ciurzyński1, Piotr Bienias1, Katarzyna Irzyk1
1Department of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland.
Systemic sclerosis (SSc) patients show impaired left and right ventricular diastolic function, which worsens over time for the left ventricle. Elevated tissue inhibitors of metalloproteinase-1 (TIMP-1) levels correlate with diastolic dysfunction in SSc.
Area of Science:
- Cardiology
- Rheumatology
- Biomarkers
Background:
- Limited data exist on ventricular diastolic function in systemic sclerosis (SSc).
- The relationship between diastolic dysfunction and matrix remodeling biomarkers in SSc is not well-defined.
Purpose of the Study:
- To assess left ventricular (LV) and right ventricular (RV) diastolic function in SSc patients.
- To evaluate changes in diastolic function over time (≥1 year follow-up).
- To investigate the association between diastolic function and serum tissue inhibitors of metalloproteinase-1 (TIMP-1) levels.
Main Methods:
- Prospective study of 111 SSc patients and 21 controls.
- Transthoracic echocardiography for LV and RV diastolic function assessment.
- Serum TIMP-1 levels measured at baseline and follow-up (mean 3.0 ±1.1 years).
Main Results:
- Impaired LV relaxation in 34% of SSc patients vs. 5% of controls (p < 0.001).
- Lower mean E/A ratio in SSc patients, decreasing significantly after follow-up (p = 0.02).
- Elevated serum TIMP-1 levels at follow-up correlated with echocardiographic parameters (E/E').
Conclusions:
- LV and RV diastolic relaxation are impaired in SSc patients.
- LV diastolic function deteriorates over time in SSc.
- TIMP-1 serum levels are linked to LV diastolic function and matrix remodeling in SSc.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pathophysiology of Heart Failure
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

